⌘K

Login Start Free

Home/Filings/4/0001171843-15-001513

4//SEC Filing

Xenon Pharmaceuticals Inc. 4

Accession 0001171843-15-001513

$XENECIK 0001582313operating

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:50 PM ET

Size

5.3 KB

Accession

0001171843-15-001513

Insider Transaction Report

Form 4

Period: 2015-03-17

Xenon Pharmaceuticals Inc.XENE

COHEN CHARLES J.

VP, Biology

Transactions

Award
Stock Option (Right to Buy)
2015-03-17+35,000→ 35,000 total
Exercise: $17.76Exp: 2025-03-16→ Common Shares (35,000 underlying)

Footnotes (1)

[F1]Vesting 25% on January 1, 2016, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Documents

1 file

4
gff4_cohen031915.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeoperating

IncorporatedBritish Columbia, Canada

Related Parties

1

filerCIK 0001582313

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 8:50 PM ET
Size: 5.3 KB

View on SEC.gov